Clindamycin-resistant Streptococcus pyogenes: report of a case

Diagnostic Microbiology and Infectious Disease
Stephen R WalshMarlene L Durand

Abstract

A sentinel isolate of clindamycin-resistant Streptococcus pyogenes from a case of mixed aerobic-anaerobic necrotizing fasciitis prompted our clinical laboratory to change its protocol and subsequently perform routine susceptibility testing on all S. pyogenes isolated from blood and soft tissue specimens. Emerging clindamycin resistance may have serious implications in the treatment of severe S. pyogenes infections.

References

Nov 1, 1979·American Journal of Diseases of Children·S MaruyamaY Satake
Jul 1, 1991·Antimicrobial Agents and Chemotherapy·R Leclercq, P Courvalin
Jun 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D L StevensS P Hackett
Mar 1, 1995·Antimicrobial Agents and Chemotherapy·B Weisblum
Jan 25, 1996·The New England Journal of Medicine·A L Bisno, D L Stevens
Jan 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·E L Kaplan
Dec 20, 2000·Antimicrobial Agents and Chemotherapy·B Vester, S Douthwaite
Apr 19, 2002·The New England Journal of Medicine·Judith M MartinEllen R Wald
Jun 28, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alan L BisnoUNKNOWN Infectious Diseases Society of America
Jul 29, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Dennis L Stevens

❮ Previous
Next ❯

Citations

Jun 19, 2010·Internal Medicine·Taro Shimizu, Yasuharu Tokuda
Oct 12, 2007·Expert Opinion on Pharmacotherapy·David Guay
Sep 30, 2015·The International Journal of Lower Extremity Wounds·Elisabetta IacopiAlberto Piaggesi
Jan 27, 2021·Infectious Disease Clinics of North America·Rachel J Bystritsky
Mar 20, 2008·Farmacia hospitalaria : órgano oficial de expresión científica de la Sociedad Española de Farmacia Hospitalaria·P M Olaechea AstigarragaUNKNOWN INfectious Diseases Working Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.